Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Examining the Appeal of Nicotine Pouches in Ohio Appalachia
NCT05236894Phase 1Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Mar 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicotine oral pouch in Tobacco Use Disorder (TUD) (6 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoint: Plasma nicotine concentration at t=30 minutes. Started Mar 2022; status: completed.
02
Drugs
nicotine oral pouch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05236894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05236894.